The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors.
 
Dongmei Ji
No Relationships to Disclose
 
Yao Weitao
No Relationships to Disclose
 
Xiangmin Tong
No Relationships to Disclose
 
Chenping Zhang
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Yuhong Zhou
No Relationships to Disclose
 
Zhendong Li
No Relationships to Disclose
 
Yaotiao Deng
No Relationships to Disclose
 
Gang Huang
No Relationships to Disclose
 
Zhiwei Tao
No Relationships to Disclose
 
Yulong Zheng
No Relationships to Disclose
 
Gang Wang
No Relationships to Disclose
 
Guowen Liu
No Relationships to Disclose
 
Jing Chen
No Relationships to Disclose
 
Xiaohui Niu
No Relationships to Disclose
 
Jilong Yang
No Relationships to Disclose
 
Weijia Pang
Employment - AstraZeneca; Immvira; MSD
 
Min Zhao
No Relationships to Disclose
 
Xichun Hu
Honoraria - AstraZeneca; Daiichi Sankyo/Lilly; Eisai; Hengrui Pharmaceutical; Lilly; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca